Advertisement
Screener

REZOLUTE, INC. (RZLT) ROI

Rezolute, Inc. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

Available history
2018-12-31 to 2018-12-31
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2018-12-31523.57%-$24.99M-$4.16M-$4.77M

Annual ROI

DateROINet income 12 monthDebt plus equity

Similar stocks

Stock NameCountryMarket CapPE Ratio
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Vogenx, Inc. (VOGX)United States$0.355B
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43